| AD | Alzheimer’s disease |
| ADCS-ADL | Alzheimer’s Disease Cooperative Study–Activities of Daily Living |
| AFAGI | Asociación de Familiares de Alzheimer y otras Demencias de Gipuzkoa |
| Aβ42 | Amyloid beta 1–42 peptide |
| APOE | Apolipoprotein E |
| ARIA | Amyloid-Related Imaging Abnormalities |
| AT(N) | Amyloid, Tau, and Neurodegeneration classification framework |
| A+/T+/N+/V+ | Positive for Amyloid/Tau/Neurodegeneration/Vascular burden |
| BMI | Body Mass Index |
| BNT | Boston Naming Test |
| CAD | Cognitive Age Delta |
| CITA | Center for Research and Memory Clinic, CITA-Alzheimer Foundation |
| CI | Confidence Interval |
| CMBs | Cerebral Microbleeds |
| cSS | Cortical Superficial Siderosis |
| CSF | Cerebrospinal Fluid |
| CR | Cognitive Reserve |
| CU | Cognitively Unimpaired |
| CUA−V−/ | Cognitively Unimpaired Amyloid- (A-T-N-) and Vascular– |
| CUA+ | Cognitively Unimpaired Amyloid+ (A+ and T and N+ or -) and Vascular– |
| CUV+ | Cognitively Unimpaired Vascular+ and Amyloid- (A-T-N-) |
| DNA | Deoxyribonucleic Acid |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| ENRICA | Estudio de Nutrición y Riesgo Cardiovascular (Spanish Study on Nutrition and Cardiovascular Risk) |
| FCSRT | Free and Cued Selective Reminding Test |
| FDR | False Discovery Rate |
| FLAIR | Fluid-Attenuated Inversion Recovery |
| GAP | Gipuzkoa Alzheimer Project |
| GLM | General Linear Model |
| GRE | Gradient-Recalled Echo |
| HADS | Hospital Anxiety and Depression Scale |
| HbA1c | Glycated Hemoglobin |
| HDL | High-Density Lipoprotein |
| IPAQ | International Physical Activity Questionnaire |
| IQR | Interquartile Range |
| IWG-3 | International Working Group Criteria, 3rd Revision |
| JLO | Judgment of Line Orientation Test |
| LDL | Low-Density Lipoprotein |
| M@T | Memory Alteration Test |
| MCI | Mild Cognitive Impairment |
| MMSE | Mini-Mental State Examination |
| MRI | Magnetic Resonance Imaging |
| MTA | Medial Temporal Atrophy scale |
| NPI | Neuropsychiatric Inventory |
| NPS | Neuropsychological Profile |
| OSA | Obstructive Sleep Apnea |
| PCR | Polymerase Chain Reaction |
| p-tau | Phosphorylated tau |
| t-tau | Total tau |
| PSQ | Perceived Stress Questionnaire |
| PSQI | Pittsburgh Sleep Quality Index |
| ROCF | Rey–Osterrieth Complex Figure Test |
| SVD | Small Vessel Disease |
| SWI | Susceptibility-Weighted Imaging |
| STRIVE/STRIVE-2 | Standards for Reporting Vascular Changes on Neuroimaging (1st and 2nd editions) |
| SUN | Seguimiento Universidad de Navarra |
| TMT-A/TMT-B | Trail Making Test Parts A and B |
| TOPF | Wechsler Test of Premorbid Functioning |
| UPDRS-III | Unified Parkinson’s Disease Rating Scale, Part III (motor section) |
| V | Vascular status (burden) |
| WAIS-III | Wechsler Adult Intelligence Scale, 3rd Edition |
| WMH | White Matter Hyperintensities |